Listing Page

Tag: FDA

What You Need to Know About Post-Approval Change Pathways
Post-approval changes (PACs) – changes made to the drug substance manufacturing process after receiving...
Read More >
Why a CDMO Might Be the Best Place to Find Regulatory Support
The main goal for any drug company is achieving a speedy path to market. While many obstacles threaten...
Read More >
2 Key Factors to Accelerate Drug Approvals: Expertise and Relationships
Drug approvals are often complex and time-consuming, even for generic versions of approved medications....
Read More >
How to Stay Compliant in a Changing Pharma Regulatory Landscape
In 2012, contaminated medications from the New England Compounding Center (NECC) caused a meningitis...
Read More >
LGM Pharma Expands Client Service Offerings Supporting The Provision of High Quality Active Pharmaceutical Ingredients (APIs) For 503B Outsourcing Facilities
Erlanger, Kentucky, June 24, 2019 – LGM Pharma, LLC, a leader in Active Pharmaceutical Ingredient (API)...
Read More >